Back to results
US 11,141,399 B2Granted
Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis
AssigneeAmarin Pharmaceuticals Ireland Limited
InventorsMehar Manku, Pierre Wicker, Rene Braeckman, Paresh Soni, Joseph S. Zakrzewski
Life of this patent
Estimating the term…
Abstract
In various embodiments, the present invention provides methods of treating and/or preventing NASH and/or PBC comprising administering to a subject in need thereof a pharmaceutical composition comprising eicosapentaenoic acid or a derivative thereof.
Claims11
A method of inhibiting Farnesoid X receptors (“FXR”) in a subject having triglyceride levels of at least about 500 mg/dL, the method comprising administering orally to the subject about 4 g of ethyl eicosapentaenoate per day.
Dependencies are inferred from the claim text.